These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2829716)

  • 21. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors.
    Durcik M; Tammela P; Barančoková M; Tomašič T; Ilaš J; Kikelj D; Zidar N
    ChemMedChem; 2018 Jan; 13(2):186-198. PubMed ID: 29206345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification.
    Xue W; Li X; Ma G; Zhang H; Chen Y; Kirchmair J; Xia J; Wu S
    Eur J Med Chem; 2020 Feb; 188():112022. PubMed ID: 31901744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quinolones: pharmacology.
    Verbist L
    Pharm Weekbl Sci; 1986 Feb; 8(1):22-5. PubMed ID: 3008075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in DNA gyrase-targeted antimicrobial agents.
    Dighe SN; Collet TA
    Eur J Med Chem; 2020 Aug; 199():112326. PubMed ID: 32460040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: structure based design, synthesis, SAR and antimicrobial activity.
    Yule IA; Czaplewski LG; Pommier S; Davies DT; Narramore SK; Fishwick CW
    Eur J Med Chem; 2014 Oct; 86():31-8. PubMed ID: 25137573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antibacterial activity of the C-7 side chain of 3-aminoquinazolinediones.
    Hutchings KM; Tran TP; Ellsworth EL; Watson BM; Sanchez JP; Showalter HD; Stier MA; Shapiro M; Themis Joannides E; Huband M; Nguyen DQ; Maiti S; Li T; Tailor J; Thomas G; Ha C; Singh R
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5087-90. PubMed ID: 18752951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advancements in the medicinal chemistry of bacterial type II topoisomerase inhibitors.
    Jaswal S; Nehra B; Kumar S; Monga V
    Bioorg Chem; 2020 Nov; 104():104266. PubMed ID: 33142421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
    Ellsworth EL; Tran TP; Showalter HD; Sanchez JP; Watson BM; Stier MA; Domagala JM; Gracheck SJ; Joannides ET; Shapiro MA; Dunham SA; Hanna DL; Huband MD; Gage JW; Bronstein JC; Liu JY; Nguyen DQ; Singh R
    J Med Chem; 2006 Nov; 49(22):6435-8. PubMed ID: 17064062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro biological evaluation of novel broad-spectrum isothiazolone inhibitors of bacterial type II topoisomerases.
    Charrier C; Salisbury AM; Savage VJ; Moyo E; Forward H; Ooi N; Cheung J; Metzger R; McGarry D; Walker R; Cooper IR; Ratcliffe AJ; Stokes NR
    J Antimicrob Chemother; 2016 Oct; 71(10):2831-9. PubMed ID: 27353465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure activity relationship of C-2 ether substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-5).
    Singh SB; Kaelin DE; Meinke PT; Wu J; Miesel L; Tan CM; Olsen DB; Lagrutta A; Fukuda H; Kishii R; Takei M; Takeuchi T; Takano H; Ohata K; Kurasaki H; Nishimura A; Shibata T; Fukuda Y
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3630-5. PubMed ID: 26152426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents.
    Khan T; Sankhe K; Suvarna V; Sherje A; Patel K; Dravyakar B
    Biomed Pharmacother; 2018 Jul; 103():923-938. PubMed ID: 29710509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2).
    Singh SB; Kaelin DE; Wu J; Miesel L; Tan CM; Black T; Nargund R; Meinke PT; Olsen DB; Lagrutta A; Lu J; Patel S; Rickert KW; Smith RF; Soisson S; Sherer E; Joyce LA; Wei C; Peng X; Wang X; Fukuda H; Kishii R; Takei M; Takano H; Shibasaki M; Yajima M; Nishimura A; Shibata T; Fukuda Y
    Bioorg Med Chem Lett; 2015 May; 25(9):1831-5. PubMed ID: 25851938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mode of action of the quinolone antimicrobial agents.
    Hooper DC; Wolfson JS
    Rev Infect Dis; 1988; 10 Suppl 1():S14-21. PubMed ID: 2831608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and properties of (4S)-7-(4-amino-2-substituted-pyrrolidin-1-yl)quinolone-3-carboxylic acids.
    Rosen T; Chu DT; Lico IM; Fernandes PB; Marsh K; Shen L; Cepa VG; Pernet AG
    J Med Chem; 1988 Aug; 31(8):1598-611. PubMed ID: 2840501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and In Silico Molecular Docking Studies on Substituted Piperic Acid Derivatives as Inhibitors of Bacterial DNA Gyrase.
    Chopra B; Dhingra AK; Prasad DN; Bhardwaj S; Dubey S
    Curr Comput Aided Drug Des; 2020; 16(3):281-294. PubMed ID: 31288729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-silico driven design and development of spirobenzimidazo-quinazolines as potential DNA gyrase inhibitors.
    Korrapati SB; Yedla P; Pillai GG; Mohammad F; Ch VRR; Bhamidipati P; Amanchy R; Syed R; Kamal A
    Biomed Pharmacother; 2021 Feb; 134():111132. PubMed ID: 33360050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and structure-activity relationships of novel 15-membered macrolides: Quinolone/quinoline-containing sidechains tethered to the C-6 position of azithromycin acylides.
    Fan BZ; Hiasa H; Lv W; Brody S; Yang ZY; Aldrich C; Cushman M; Liang JH
    Eur J Med Chem; 2020 May; 193():112222. PubMed ID: 32200200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, antibacterial evaluation, and DNA gyrase inhibition profile of some new quinoline hybrids.
    Rizk OH; Bekhit MG; Hazzaa AAB; El-Khawass EM; Abdelwahab IA
    Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900086. PubMed ID: 31389630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological evaluation of oxazolidinone-quinolone hybrids.
    Hubschwerlen C; Specklin JL; Sigwalt C; Schroeder S; Locher HH
    Bioorg Med Chem; 2003 May; 11(10):2313-9. PubMed ID: 12713843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.